Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion: Full Deal Analysis
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals in an all-cash deal valued at approximately $10 billion, making…
Biogen to Acquire Apellis Pharma in $5.6 Billion Deal to Boost Rare Disease Growth
In one of the biggest biotechnology deals of 2026, Biogen has announced the acquisition of Apellis Pharmaceuticals for…

































































